# Clinical Outcomes of GENOSS PCB for Femoropopliteal Artery Disease

> **NCT07399080** · — · ENROLLING_BY_INVITATION · sponsor: **Genoss Co., Ltd.** · enrollment: 200 (estimated)

## Conditions studied

- PTA (Percutaneous Transluminal Angioplasty )
- Femoropopliteal Artery Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07399080
- **Lead sponsor:** Genoss Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-07-01
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-06-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07399080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07399080, "Clinical Outcomes of GENOSS PCB for Femoropopliteal Artery Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07399080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*